Search results
Roche stock jumps as obesity drug shows 'encouraging results' in Phase I trial By Investing.com
Investing.com· 4 days agoRoche stock jumps as obesity drug shows 'encouraging results' in Phase I trial
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks via Yahoo Finance· 3 days agoData from the study shows that nearly half of the patients who received Roche's (RHHBY)...
Roche shares jump on obesity drug results from early-stage trial
Reuters via AOL· 4 days ago(Reuters) -Roche shares gained as much as 4.7% on Thursday after an early-stage trial showed that a...
Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
Barrons.com· 3 days agoSTOCK ALERT Roche unveiled impressive early-stage results in a small trial of a weight-loss drug...
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
The Wall Street Journal· 3 days agoRoche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial,...
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
Benzinga via Yahoo Finance· 3 days agoThursday, Genentech, a unit of Roche Holdings AG (OTC:RHHBY), released results from the Phase 1b...
FDA Approves Roche’s HPV Self-Collection Solution, Allowing Patients to Gather Their Own Samples in...
Pharmaceutical Executive Magazine· 4 days agoRoche announced that the FDA has approved its human papillomavirus(HPV) self-collection solution,...
Exploring Dividend Stocks In Switzerland With Compagnie Financière Tradition And Two Others
Simply Wall St. via Yahoo Finance· 6 days agoSwiss stocks showed modest gains in a recent trading session, reflecting cautious investor sentiment...
Baldwin Insurance executive sells over $750k in company stock By Investing.com
Investing.com· 6 days agoOn May 9, Roche sold 17,968 shares at a weighted average price of $30.00, with individual sales...
Selling Buzz: Analog Devices Inc. [ADI] Chair & CEO ROCHE VINCENT sells 10,000 shares of the company...
Knox Daily· 3 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Analog Devices Inc. shares valued at $1,970,600 ...